72 / 100 SEO Score

Dr. Pan Wang | Neuroscience | Best Researcher Award

Postdoctoral Researcher at Affiliated First Hospital of Zhejiang University School of Medicine, China.

Dr. Pan Wang is a postdoctoral researcher at the Department of Pathology, Zhejiang University School of Medicine. With a background in human anatomy, embryology, and pathology, Dr. Wang’s research focuses on neurodegenerative diseases, particularly Alzheimer’s and Parkinson’s disease. His work explores molecular pathways, extracellular vesicles, and neurovascular mechanisms in disease pathogenesis and diagnosis.

Publication Profile

Scopus

Educational Details

  • Ph.D. in Human Anatomy and Embryology – China Medical University, China (2016-2020)

  • M.S. in Human Anatomy and Embryology – Jinzhou Medical University, China (2009-2012)

  • B.S. in Clinical Medicine – Jinzhou Medical University, China (2004-2009)

Professional Experience

Dr. Wang has extensive experience in neuropathology research. Since 2021, he has been a postdoctoral researcher at Zhejiang University, investigating spatial transcriptomics and disease biomarkers in Alzheimer’s and Parkinson’s disease. Before that, he worked as an Assistant Researcher in the Department of Neurobiology at Jinzhou Medical University (2012–2016), where he contributed to studies on synaptic dysfunction, neuroinflammation, and vascular pathology in neurodegenerative conditions.

Research Interest

  • Molecular mechanisms of Alzheimer’s & Parkinson’s disease

  • Neurovascular interactions and blood-brain barrier dysfunction

  • Role of extracellular vesicles in neurodegeneration

  • Spatial transcriptomics and precision diagnostics in neuropathology

Author Metrics

As of April 2025, Dr. Pan Wang has authored over 8 publications, with a total citation count exceeding 3,200 and an h-index of 25. These metrics reflect the impact and recognition of his research contributions in the scientific community.

Top Noted Publication

  • Molecular pathways and diagnosis in spatially resolved Alzheimer’s hippocampal atlas

    • Journal: Neuron (2025)

    • DOI: 10.1016/j.neuron.2025.03.002

    • Summary: Investigates molecular mechanisms in the hippocampus using spatial transcriptomics to advance Alzheimer’s disease diagnostics.

  • α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis

    • Journal: Translational Neurodegeneration (2023)

    • DOI: 10.1186/s40035-023-00372-y

    • Summary: Identifies the role of astrocytic extracellular vesicles in the spread of α-synuclein and their potential as diagnostic markers in Parkinson’s disease.

  • Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer’s disease

    • Journal: Neural Regeneration Research (2021)

    • DOI: 10.4103/1673-5374.295349

    • Summary: Explores melatonin’s neuroprotective effects on microvascular dysfunction in Alzheimer’s disease.

  • Regulatory role of melatonin in Notch1 signaling pathway in cerebral cortex of Aβ(1-42)-induced Alzheimer’s disease rat model

    • Journal: Molecular Biology Reports (2023)

    • DOI: 10.1007/s11033-022-08213-3

    • Summary: Examines melatonin’s modulation of Notch1 signaling in Alzheimer’s pathology.

  • Effects of the genetic knockout of the β-1,3-galactosyltransferase 2 on spatial learning and neurons in the adult mouse hippocampus and somatosensory cortex

    • Journal: Neuroreport (2023)

    • DOI: 10.1097/wnr.0000000000001857

    • Summary: Investigates the impact of β-1,3-galactosyltransferase 2 knockout on cognitive functions and neurodevelopment.

  • Protective effect of melatonin on soluble Aβ1-42-induced memory impairment, astrogliosis, and synaptic dysfunction via the Musashi1/Notch1/Hes1 signaling pathway in the rat hippocampus

    • Journal: Alzheimer’s Research & Therapy (2016)

    • DOI: 10.1186/s13195-016-0206-x

    • Summary: Demonstrates melatonin’s protective role against Aβ1-42-induced neurotoxicity.

  • Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson’s disease

    • Journal: Glia (2022)

    • DOI: 10.1002/glia.24109

    • Summary: Identifies VEGFA as a critical factor in blood-brain barrier dysfunction in Parkinson’s disease.

  • Erythrocytic α-Synuclein and the Gut Microbiome: Kindling of the Gut-Brain Axis in Parkinson’s Disease

    • Journal: Movement Disorders (2024)

    • DOI: [Pending]

    • Summary: Explores the gut-brain axis in Parkinson’s disease, focusing on erythrocytic α-synuclein interactions with the microbiome.

Conclusion

Dr. Pan Wang is a highly qualified candidate for the Best Researcher Award, given his impactful contributions to neuroscience, strong publication record, and high citation count. His expertise in neurodegenerative diseases and innovative research techniques positions him as a leading figure in his field.

To further strengthen his candidacy, expanding international collaborations, securing research funding, and taking on leadership roles would elevate his profile for top-tier research awards.

Pan Wang | Neuroscience | Best Researcher Award

You May Also Like